Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-737 Cr₹-769 Cr₹-561 Cr₹-1,543 Cr₹-524 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-737 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-737 Cr
Mar2025₹-769 Cr
Mar2024₹-561 Cr
Mar2023₹-1,543 Cr
Mar2022₹-524 Cr

How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-737 Cr
Negative
Mar2025 ₹-769 Cr
Negative
Mar2024 ₹-561 Cr
Negative
Mar2023 ₹-1,543 Cr
Negative
Mar2022 ₹-524 Cr -

Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹45,628.7 Cr -1.2% 5% 5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -1.4% 6.3% 7.8% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -1.8% 20.6% 70.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.9% 2.4% 22.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr 0.8% 12.6% 12.3% Stock Analytics
CIPLA ₹111,731.0 Cr -2.4% 4.4% -8.3% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.2%

5%

5.7%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses